Stocks / SRPT
Stock profile · 銘柄

Sarepta Therapeutics, Inc. - Common Stock (SRPT)

SRPT did not make Shishin's board on 2026-07-14: not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a view on the company. The figures below are research data, the mechanical screen result and the momentum, trend, and volatility indicators the engines observe, not investment advice.

Shishin's live daily signals are published each morning on the rankings board.

Shishin Score19
In today's boardNo
SetupOTHER
Last close$18.82
SectorBiotechnology
Today's scan · 2026-07-14
Not screenedComposite 19/100

SRPT did not make Shishin's board on 2026-07-14: not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a view on the company.

Position
33
Thrust
27
Breakout
20
Base
35
Volatility
54
Liquidity
50
Indicators · as of 2026-07-14
ADR · 20d5.7%
ATR · 145.4%
RSI · 1455
Return · 30d+9%
Return · 60d-13%
Above MA206%
Above MA505%
Range · 20d39%
MA stack1
From 52w high-26%
$ Vol · 30d$32M
Vol ratio0.74×
Frequently asked

Is SRPT a Shishin signal?

On 2026-07-14, SRPT is not in Shishin's board. Not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a recommendation.

What is SRPT's Shishin momentum score?

As of 2026-07-14, SRPT's composite momentum score is 19/100, a weighted blend of momentum, trend, and volatility indicators on a 0 to 100 scale.

Why didn't SRPT make the board?

Not in a strong uptrend (60-day return under 30%, or below its 50-day average). Shishin's board takes only the names that clear its liquidity, trend, and score thresholds for the active market regime.

Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.

Today's full rankings →Rate your watchlist →All covered stocks →